Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

FOXN1 gene variants cause low T cells and immune issues from birth.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

No systemic treatment for alopecia areata has strong evidence of effectiveness.